Vasar V - Search Results

1

Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression.

Tammiste A, Jiang T, Fischer K, Mägi R, Krjutškov K, Pettai K, Esko T, Li Y, Tansey KE, Carroll LS, Uher R, McGuffin P, Võsa U, Tšernikova N, Saria A, Ng PC, Eller T, Vasar V, Nutt DJ, Maron E, Wang J, Metspalu A. Tammiste A, et al. Among authors: vasar v. J Psychopharmacol. 2013 Oct;27(10):915-20. doi: 10.1177/0269881113499829. Epub 2013 Aug 7. J Psychopharmacol. 2013. PMID: 23926243 Clinical Trial.

2

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

Eller T, Vasar V, Shlik J, Maron E. Eller T, et al. Among authors: vasar v. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):445-50. doi: 10.1016/j.pnpbp.2007.09.015. Epub 2007 Sep 26. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 17976882 Clinical Trial.

3

Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.

Maron E, Tammiste A, Kallassalu K, Eller T, Vasar V, Nutt DJ, Metspalu A. Maron E, et al. Among authors: vasar v. Eur Neuropsychopharmacol. 2009 Jun;19(6):451-6. doi: 10.1016/j.euroneuro.2009.01.010. Epub 2009 Mar 9. Eur Neuropsychopharmacol. 2009. PMID: 19272758 Clinical Trial.

4

Thyroid autoimmunity and treatment response to escitalopram in major depression.

Eller T, Metsküla K, Talja I, Maron E, Uibo R, Vasar V. Eller T, et al. Among authors: vasar v. Nord J Psychiatry. 2010 Aug;64(4):253-7. doi: 10.3109/08039480903487533. Nord J Psychiatry. 2010. PMID: 20088751

5

Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.

Tõru I, Shlik J, Maron E, Vasar V, Nutt DJ. Tõru I, et al. Among authors: vasar v. Psychopharmacology (Berl). 2006 May;186(1):107-12. doi: 10.1007/s00213-006-0351-1. Epub 2006 Mar 16. Psychopharmacology (Berl). 2006. PMID: 16541242 Clinical Trial.

6

Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder.

Eller T, Vasar V, Shlik J, Maron E. Eller T, et al. Among authors: vasar v. J Psychopharmacol. 2009 Sep;23(7):854-8. doi: 10.1177/0269881108091077. Epub 2008 Jun 18. J Psychopharmacol. 2009. PMID: 18562403

7

Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder.

Traks T, Koido K, Eller T, Maron E, Kingo K, Vasar V, Vasar E, Kõks S. Traks T, et al. Among authors: vasar v, vasar e. BMC Med Genet. 2008 Dec 16;9:111. doi: 10.1186/1471-2350-9-111. BMC Med Genet. 2008. PMID: 19087313 Free PMC article.

8

The role of IL-2 and soluble IL-2R in depression and antidepressant response.

Eller T, Vasar V, Shlik J, Maron E. Eller T, et al. Among authors: vasar v. Curr Opin Investig Drugs. 2009 Jul;10(7):638-43. Curr Opin Investig Drugs. 2009. PMID: 19579169 Review.

9

Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes.

Koido K, Eller T, Kingo K, Kõks S, Traks T, Shlik J, Vasar V, Vasar E, Maron E. Koido K, et al. Among authors: vasar v, vasar e. J Psychiatr Res. 2010 Apr;44(5):275-7. doi: 10.1016/j.jpsychires.2009.09.001. Epub 2009 Sep 27. J Psychiatr Res. 2010. PMID: 19786281

10

Soluble interleukin-2 receptor and tumor necrosis factor levels in depressed patients in Estonia.

Eller T, Aluoja A, Maron E, Vasar V. Eller T, et al. Among authors: vasar v. Medicina (Kaunas). 2009;45(12):971-7. Medicina (Kaunas). 2009. PMID: 20173400 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters